Star Equity Holdings Inc 's ROA from the first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Star Equity Holdings Inc 's ROA in the first quarter of 2026?
Star Equity Holdings Inc recorded a cumulative net loss of $-4 million during 12 months ending in the first quarter of 2026, resulting in a negative return on assets (ROA) of -3.72%.

However, within the Healthcare sector 244 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2026 quarter, so far to 2872, from total ROA ranking in the fourth quarter of 2025 at 3092.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Total Assets Change	17.3 %	52.66 %	52.11 %	25.3 %	34.72 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-4	-1	-2	-2	-9
Return On Assets (TTM)	-3.72 %	-1.21 %	-2.17 %	-2.68 %	-12.44 %
STRR's Total Ranking	# 2872	# 3092	# 2814	# 2853	# 3351
Total Assets (TTM) in million	101	106	110	93	86
Seq. Total Assets Change	-4.6 %	-4.35 %	18.29 %	8.67 %	24.16 %
Seq. Net Income Change	-	-	-	-	-

STRR's 5 Years Annual ROA >> Back to STRR Management Effectiveness >> Compare STRR ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 78
Sector	# 245
Overall	# 2852

Return On Assets Statistics
High	Average	Low
47.71 %	0.42 %	-28.57 %
(Sep 30 2015)		(Dec 31 2013)

Financial Statements
Star Equity Holdings Inc 's Assets	$ 101 million	STRR's Balance sheet
Star Equity Holdings Inc 's Income	$ -4 million	Quarterly STRR's Income Statement
STRR's Income by Division		See STRR's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	52.66 %	0.81 %	-2.03 %	7.74 %	-26.4 %
Total Assets in million	106	69	69	70	65
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-6	-10	25	-5	-3
Annual Return On Assets	-5.61 %	-15.1 %	36.64 %	-7.5 %	-4.59 %

STRR's 5 Years Annual ROA >> Back to STRR Management Effectiveness >> Compare STRR ROA to its Competitors

More Return On Assets Ratios
STRR's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
STRR's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for STRR's Competitors
Subscribers only: Roa for Star Equity Holdings Inc 's Suppliers
Subscribers only: Return On Assets for STRR's Customers

You may also want to know
STRR's Roi	STRR's Inventory Turnover Ratio	STRR's Growth Rates	STRR's Dividend Comparisons
	STRR's Profitability Ratios	STRR's Asset Turnover Ratio	STRR's Dividend Growth
STRR's Roe	STRR's Valuation Ratios	STRR's Financial Strength Ratios	STRR's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2026, within Healthcare Sector

ROA

Date modified: 2026-09-08T15:11:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.